Pharmaceutical Scientist
US Food and Drug Administration
Silver Spring, Maryland
Dr. Mahmud is a Process and Facility Reviewer at the Office of Pharmaceutical Manufacturing Assessment (OPMA), US Food and Drug Administration (FDA). As a regulatory reviewer, Dr. Mahmud assesses Manufacturing Process and Facilities for drug applications (abbreviated new drug applications (ANDAs), new drug applications (NDAs), and investigational new drugs (INDs)) to better determine approvability and manufacturing risks of pharmaceutical products intended to be marketed in the United States.
Dr. Mahmud obtained his Ph. D. degree in Pharmacy and Pharmaceutical Sciences from the University of Alberta, Canada in 2008. He performed post-doctoral research at the University of Pennsylvania (department of chemical and biomolecular engineering) for 3 years. Prior joining to FDA in 2019, Dr. Mahmud served as a research scientist at the Frederick National Laboratory for Cancer Research for more than 6 years.
The Risks Triggering FDA’s Pre-Approval Inspection for a Manufacturing Facility
Monday, October 23, 2023
3:00 PM – 3:15 PM ET
Tuesday, October 24, 2023
3:00 PM – 4:00 PM ET